What is the initial test to order for suspected kidney disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Testing for Suspected Kidney Disease

The initial test to order for suspected kidney disease should be both a urine albumin-to-creatinine ratio (uACR) and serum creatinine with estimated glomerular filtration rate (eGFR). 1

Rationale for Dual Testing Approach

Urine Albumin-to-Creatinine Ratio (uACR)

  • Preferred method for detecting kidney damage as it provides a sensitive marker for chronic kidney disease due to diabetes, glomerular disease, and hypertension 1
  • More sensitive than standard dipstick tests, especially at lower levels of proteinuria 1
  • Can detect microalbuminuria (30-300 mg/g), which represents early kidney damage before progression to overt proteinuria 2
  • Should be performed on a spot urine sample, preferably first morning void 1, 2

Serum Creatinine with eGFR

  • Essential for assessing kidney function 1
  • Should be calculated using a GFR estimating equation rather than relying on serum creatinine alone 1
  • Provides classification of kidney function according to GFR categories (G1-G5) 1

Testing Algorithm

  1. Initial Assessment:

    • Order both uACR and serum creatinine with eGFR calculation 1
    • Use first morning void urine sample when possible 1
    • Ensure laboratory reports eGFR in addition to serum creatinine 1
  2. Interpretation of Results:

    • Normal: uACR <30 mg/g and eGFR ≥60 ml/min/1.73m² 2
    • Kidney damage: uACR ≥30 mg/g regardless of eGFR 1
    • Reduced kidney function: eGFR <60 ml/min/1.73m² regardless of uACR 1
    • CKD diagnosis: Abnormalities persisting for >3 months 1
  3. Confirmation:

    • If uACR is elevated (≥30 mg/g), repeat within 3 months to confirm persistence 1
    • For borderline eGFR (45-59 ml/min/1.73m²) without albuminuria, consider cystatin C measurement for confirmation 1

Special Considerations

High-Risk Populations

More vigilant screening is recommended for:

  • Patients with diabetes 1
  • Patients with hypertension 1, 2
  • African American individuals 1, 2
  • Patients with hepatitis C virus coinfection 1
  • Older adults 1

Technical Aspects

  • The ratio of albumin to creatinine corrects for variations in urine concentration 1
  • uACR is more accurate than total protein-to-creatinine ratio (uPCR) for early detection of kidney disease 2, 3
  • Point-of-care testing for uACR can facilitate immediate clinical decision-making 4

Common Pitfalls to Avoid

  • Don't rely on standard dipstick alone: Standard dipsticks have lower sensitivity for detecting microalbuminuria 1, 5
  • Don't use isolated serum creatinine: Creatinine alone without eGFR calculation is insufficient 1
  • Don't ignore borderline results: Values near cutoff points should be confirmed with repeat testing 1
  • Don't forget to assess chronicity: CKD requires persistence of abnormalities for >3 months 1

By following this dual testing approach of uACR and eGFR, clinicians can effectively screen for, diagnose, and stage kidney disease, enabling earlier intervention to prevent disease progression and complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Proteinuria Detection and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.